Novel Approaches Identifying Relevant Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases-LISTEN

被引:5
|
作者
Teich, Niels [1 ,2 ]
Schulze, Hermann [3 ]
Knop, Jana [4 ]
Obermeier, Michael [5 ]
Stallmach, Andreas [6 ]
机构
[1] Internist Gemeinschaftspraxis Verdauungs & Stoffw, Leipzig, Germany
[2] Friedrich Schiller Univ Jena, Med Fac, Jena, Germany
[3] AGAPLESION Med Care Ctr, Frankfurt, Germany
[4] Takeda Pharma Vertrieb GmbH & Co KG, Jagerstr 27, D-10117 Berlin, Germany
[5] GKM Gesell Therapieforsch GmbH, Munich, Germany
[6] Jena Univ Hosp, Dept Internal Med 4, Jena, Germany
关键词
Crohn's disease; ulcerative colitis; patient relevance; self-reported experience; QUALITY-OF-LIFE; ULCERATIVE-COLITIS; OLMSTED COUNTY; PREVALENCE; CROHNS; MINNESOTA; DIAGNOSIS; IMPACT;
D O I
10.1093/crocol/otab050
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Several patient-reported outcomes (PROs) have been established and are widely used in the assessment of patients with inflammatory bowel disease (IBD). However, it has never been investigated which PRO items are experienced by and are considered most relevant for IBD patients. Methods: A review of IBD-related disease scores by a steering committee led to the identification of relevant PRO questions and assignment to 16 different PRO categories (9 symptoms and 7 impacts) that characterize patient's disease burden. In a cross-sectional study, a digital patient survey was carried out to determine the self-reported experience by multiple response, the relevance of these PRO categories by pairwise comparison and the suitability of the respective questions and answer possibilities by yes-or-no-question. Results: Sixty patients with Crohn's disease (CD) (56.7% women; mean age 40.6 years; mean disease duration 12.4 years) and 60 patients with ulcerative colitis (UC) (51.7% women; mean age 37.3 years; mean disease duration 9.0 years) participated in the patient survey. All predefined symptoms and impacts, with the exception of nausea, were experienced by at least 50% of patients. Stool urgency and pain were rated the 2 most important symptoms in CD patients with similar ratings for relevance. Stool urgency was also the most important symptom in patients with UC, followed by stool frequency. Differences in self-reported experience between CD and UC patients were seen for the symptoms of rectal bleeding, pain, and nausea. Most important impact of symptoms in both patient groups were general wellbeing followed by social activities, while sexual activity was the least relevant impact category. Conclusions: Stool urgency was the most relevant and most self-reported symptom for both CD and UC. Relevance and self-reported experience of pain and rectal bleeding differed between the 2 diseases. Therefore, the future collection of PROs should take these disease specificities into consideration. Lay Summary This study showed that stool urgency, stool frequency, and either pain for Crohn's disease patients or rectal bleeding for patients with ulcerative colitis were considered the most relevant symptoms. Thus, emphasis on patient reporting outcomes with focus on these categories is advised.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Addressing Unmet Needs of Inflammatory Bowel Disease Patients With Patient-Reported Outcomes App: A Mixed Methods Study
    Khan, Sameer
    Dasrath, Florence
    Farghaly, Sara
    Rogers, Jason
    Ullman, Thomas A.
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Moore, Shirley M.
    Atreja, Ashish
    GASTROENTEROLOGY, 2015, 148 (04) : S184 - S184
  • [42] Low compliance with remote monitoring of patient-reported outcomes via digital application in patients with inflammatory bowel disease
    Natour, O. Haj
    Ben Horin, S.
    Lipkin, M.
    Galper, A.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 1047 - 1047
  • [43] Assessment of patient readiness to engage in digital patient-reported outcomes in an Australian inflammatory bowel disease cohort
    Yiu, Th
    Rouse, S.
    Hausler, C.
    Curin, K.
    Mcguinn, N.
    Petrunic, J.
    Nielsen, A.
    Rasmussen, B.
    Chow, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 122 - 122
  • [44] Patient-Reported Outcomes in Patients with Cardiomyopathy
    Raul Angel Garcia
    Mary C. Benton
    John A. Spertus
    Current Cardiology Reports, 2021, 23
  • [45] Patient-Reported Outcomes in Patients with Cardiomyopathy
    Garcia, Raul Angel
    Benton, Mary C.
    Spertus, John A.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
  • [46] Golimumab improves patient-reported outcomes in daily practice of inflammatory rheumatic diseases in Germany
    Krueger, Klaus
    Remstedt, Sven
    Thiele, Astrid
    Hohenberger, Susanne
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (12) : 891 - 902
  • [47] Patient-reported outcomes as predictors of survival in patients with bowel cancer: a systematic review
    Claudia Rutherford
    Rachel Campbell
    Kate White
    Madeleine King
    Quality of Life Research, 2019, 28 : 2871 - 2887
  • [48] Patient-reported outcomes as predictors of survival in patients with bowel cancer: a systematic review
    Rutherford, Claudia
    Campbell, Rachel
    White, Kate
    King, Madeleine
    QUALITY OF LIFE RESEARCH, 2019, 28 (11) : 2871 - 2887
  • [49] Novel therapeutic approaches in inflammatory bowel diseases
    Atreya, Raja
    Neurath, Markus Friedrich
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (24) : 1789 - 1792
  • [50] Novel Therapeutic Approaches in Inflammatory Bowel Diseases
    Pallio, Giovanni
    BIOMEDICINES, 2023, 11 (09)